Your browser is no longer supported. Please, upgrade your browser.
Settings
CHMA Chiasma, Inc. daily Stock Chart
CHMA [NASD]
Chiasma, Inc.
Index- P/E- EPS (ttm)-1.35 Insider Own4.52% Shs Outstand57.80M Perf Week-3.24%
Market Cap224.30M Forward P/E- EPS next Y-1.03 Insider Trans0.38% Shs Float48.91M Perf Month-11.62%
Income-56.20M PEG- EPS next Q-0.39 Inst Own57.60% Short Float3.71% Perf Quarter-14.35%
Sales- P/S- EPS this Y17.10% Inst Trans2.65% Short Ratio3.43 Perf Half Y-20.16%
Book/sh1.23 P/B3.15 EPS next Y38.00% ROA-58.20% Target Price- Perf Year-24.37%
Cash/sh1.16 P/C3.34 EPS next 5Y46.30% ROE-73.50% 52W Range2.88 - 7.75 Perf YTD-21.77%
Dividend- P/FCF- EPS past 5Y-51.60% ROI- 52W High-49.94% Beta1.57
Dividend %- Quick Ratio4.40 Sales past 5Y- Gross Margin- 52W Low34.72% ATR0.19
Employees48 Current Ratio4.40 Sales Q/Q- Oper. Margin- RSI (14)29.64 Volatility3.16% 4.31%
OptionableYes Debt/Eq0.00 EPS Q/Q-101.50% Profit Margin- Rel Volume0.32 Prev Close3.89
ShortableYes LT Debt/Eq0.00 EarningsAug 10 AMC Payout- Avg Volume529.75K Price3.88
Recom1.80 SMA20-5.03% SMA50-17.12% SMA200-19.90% Volume167,999 Change-0.26%
Aug-13-20Initiated Jefferies Buy $8
Jul-31-19Initiated Piper Jaffray Overweight $11
Feb-14-19Initiated H.C. Wainwright Buy $11
Jan-17-17Downgrade Barclays Equal Weight → Underweight $5.50 → $2.50
Apr-25-16Downgrade Barclays Overweight → Equal Weight $40 → $5.50
Aug-10-15Initiated Barclays Overweight $40
Oct-01-20 07:00AM  
Sep-24-20 10:46AM  
Sep-08-20 08:00AM  
Aug-31-20 08:00AM  
Aug-17-20 02:01PM  
08:00AM  
Aug-11-20 02:30AM  
Aug-10-20 04:05PM  
Aug-03-20 04:01PM  
Jul-27-20 04:01PM  
Jul-08-20 09:21PM  
Jul-01-20 11:53AM  
09:05AM  
08:55AM  
Jun-30-20 04:30PM  
Jun-29-20 09:52AM  
Jun-26-20 01:28PM  
08:28AM  
Jun-16-20 06:14AM  
Jun-04-20 08:28PM  
May-08-20 04:30PM  
May-07-20 04:05PM  
Apr-30-20 04:01PM  
Apr-22-20 04:45PM  
Apr-08-20 07:00AM  
Mar-31-20 04:56PM  
Mar-16-20 04:05PM  
03:00PM  
Mar-09-20 04:05PM  
Feb-06-20 10:40AM  
Jan-26-20 09:17AM  
Jan-13-20 07:00AM  
Jan-10-20 07:00AM  
Dec-20-19 08:12AM  
Dec-19-19 04:05PM  
Dec-14-19 08:59PM  
Nov-26-19 04:05PM  
Nov-22-19 02:27AM  
Nov-14-19 04:05PM  
Nov-11-19 09:39AM  
Nov-05-19 04:05PM  
Nov-01-19 08:00AM  
Oct-29-19 08:00AM  
Oct-28-19 07:26AM  
Sep-25-19 08:00AM  
Sep-18-19 06:30AM  
Sep-17-19 09:00AM  
Sep-13-19 08:19AM  
Sep-05-19 04:05PM  
Aug-31-19 10:23PM  
Aug-16-19 09:00AM  
Aug-09-19 01:23PM  
Aug-08-19 04:05PM  
Aug-01-19 04:05PM  
Jul-31-19 01:48PM  
Jul-26-19 09:06AM  
Jul-25-19 04:01PM  
Jul-23-19 09:39AM  
06:00AM  
Jul-15-19 12:55PM  
Jun-28-19 02:19PM  
07:32AM  
Jun-27-19 04:10PM  
04:05PM  
Jun-06-19 07:37AM  
Jun-05-19 04:05PM  
May-30-19 08:50AM  
05:59AM  
May-24-19 06:52AM  
May-14-19 04:05PM  
May-09-19 06:45PM  
04:05PM  
Apr-30-19 04:05PM  
Apr-25-19 02:14PM  
Apr-03-19 09:25AM  
Mar-29-19 09:25AM  
Mar-28-19 05:19PM  
04:01PM  
Mar-21-19 04:05PM  
Mar-08-19 04:05PM  
Mar-04-19 04:05PM  
Feb-28-19 08:00AM  
Feb-27-19 12:56PM  
Jan-03-19 04:05PM  
Dec-21-18 09:47AM  
Nov-21-18 08:55AM  
Nov-08-18 06:03PM  
04:05PM  
Nov-01-18 08:00AM  
Oct-17-18 04:05PM  
Oct-02-18 09:10AM  
Oct-01-18 04:01PM  
Sep-20-18 01:57PM  
Sep-13-18 04:01PM  
Aug-09-18 05:47PM  
04:05PM  
Jul-25-18 04:05PM  
Jun-18-18 04:05PM  
Jun-14-18 04:05PM  
May-14-18 04:05PM  
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KANNAN RAJChief Executive OfficerJul 14Buy4.2010,00042,00017,095Jul 15 06:57 PM
Mamluk RoniDirectorFeb 20Option Exercise0.0982,1867,39782,186Feb 21 04:43 PM
Mamluk RoniDirectorFeb 20Sale4.5482,186373,1240Feb 21 04:43 PM
Mamluk RoniDirectorDec 20Option Exercise0.0961,1395,50361,139Dec 23 04:10 PM
Mamluk RoniDirectorDec 20Sale5.5161,139336,8760Dec 23 04:10 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.